These chaperones can be targeted instead of proteasomes for eliminating pathogenic ZIP13 mutant protein in the treatment of SCD-EDS as they are not usually necessary for cell survival. This evidence concerns the gene SLC39A13 and Schnyder corneal dystrophy.